Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Heart Arrest D006323 13 associated lipids
Cystitis D003556 23 associated lipids
Cholecystitis D002764 8 associated lipids
HIV Infections D015658 20 associated lipids
Subacute Sclerosing Panencephalitis D013344 3 associated lipids
Dermatitis, Allergic Contact D017449 20 associated lipids
AIDS Dementia Complex D015526 4 associated lipids
Constriction, Pathologic D003251 8 associated lipids
Medulloblastoma D008527 22 associated lipids
Zellweger Syndrome D015211 39 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Kawasaki T and Snyder F Synthesis of a novel acetylated neutral lipid related to platelet-activating factor by acyl-CoA:1-O-alkyl-2-acetyl-sn-glycerol acyltransferase in HL-60 cells. 1988 J. Biol. Chem. pmid:3422635
Borin ML et al. [Relation between the changes in Na+/H+-exchange and cytoplasmic Ca levels in platelet activation]. 1988 Biull Eksp Biol Med pmid:2844320
Smith SK and Kelly RW Effect of platelet-activating factor on the release of PGF-2 alpha and PGE-2 by separated cells of human endometrium. 1988 J. Reprod. Fertil. pmid:3422322
Criscuoli M and Subissi A Catecholamines released from the adrenal medulla exert a compensatory, protective effect at beta 2-adrenoceptors against Paf-induced death in mice. 1988 Br. J. Pharmacol. pmid:2894872
Bourdillat B et al. Hispidulin, a natural flavone, inhibits human platelet aggregation by increasing cAMP levels. 1988 Eur. J. Pharmacol. pmid:2836213
Toyofuku T et al. Pulmonary vascular response to platelet-activating factor in conscious sheep. 1988 Am. J. Physiol. pmid:3414811
Elstad MR et al. Synthesis and release of platelet-activating factor by stimulated human mononuclear phagocytes. 1988 J. Immunol. pmid:3126231
Hanss M and Dechavanne M 48740 RP, an antagonist of PAF, does not affect human plasma fibrinolysis before and after venous occlusion. 1988 Thromb. Res. pmid:3126559
Nasmith PE and Grinstein S Cytosolic calcium, oxygen consumption and the intracellular pH of stimulated neutrophils. 1988 Biosci. Rep. pmid:2840131
Dulioust A et al. Immunoregulatory functions of paf-acether. I. Effect of paf-acether on CD4+ cell proliferation. 1988 J. Immunol. pmid:2961808
Acker G et al. Role of platelet-activating factor (PAF) in the ovoimplantation in the rat: effect of the specific PAF-acether antagonist, BN 52021. 1988 Prostaglandins pmid:3129758
Altin JG and Bygrave FL Prostaglandin F2 alpha and the thromboxane A2 analogue ONO-11113 stimulate Ca2+ fluxes and other physiological responses in rat liver. Further evidence that prostanoids may be involved in the action of arachidonic acid and platelet-activating factor. 1988 Biochem. J. pmid:3128268
Bochner BS et al. Adherence of human basophils to cultured umbilical vein endothelial cells. 1988 J. Clin. Invest. pmid:3130394
Yamada K et al. Parallel inhibition of platelet-activating factor-induced protein phosphorylation and serotonin release by K-252a, a new inhibitor of protein kinases, in rabbit platelets. 1988 Biochem. Pharmacol. pmid:3128296
Crouch MF and Lapetina EG No direct correlation between Ca2+ mobilization and dissociation of Gi during platelet phospholipase A2 activation. 1988 Biochem. Biophys. Res. Commun. pmid:3132162
Fernandez-Gallardo S et al. Biosynthesis of platelet-activating factor in glandular gastric mucosa. Evidence for the involvement of the 'de novo' pathway and modulation by fatty acids. 1988 Biochem. J. pmid:2848496
Neuwirth R et al. Evidence for immunoglobulin Fc receptor-mediated prostaglandin2 and platelet-activating factor formation by cultured rat mesangial cells. 1988 J. Clin. Invest. pmid:3166467
Rossi AG et al. Stereospecific bioactions of 5-hydroxyeicosatetraenoate. 1988 FEBS Lett. pmid:3191990
Nakamura T et al. Effect of azelastine on the intracellular Ca2+ mobilization in guinea pig peritoneal macrophages. 1988 Eur. J. Pharmacol. pmid:2898372
Myers AK et al. Antagonism of PAF-induced death in mice. 1988 Prostaglandins pmid:3131837
Shalit M et al. Platelet activating factor increases expression of complement receptors on human neutrophils. 1988 J. Leukoc. Biol. pmid:2842423
Pirotzky E et al. Cyclosporine-induced nephrotoxicity: preventive effect of a PAF-acether antagonist, BN 52063. 1988 Transplant. Proc. pmid:3388505
Ward SG and Westwick J Antagonism of the platelet activating factor-induced rise of the intracellular calcium ion concentration of U937 cells. 1988 Br. J. Pharmacol. pmid:3390650
Demopoulos CA et al. Abnormal platelet response to PAF and ADP in beta-thalassaemia. 1988 Int. J. Biochem. pmid:3391336
Lichterfeld A et al. [Platelet activating factor and its possible role in bronchial asthma]. 1988 Prax Klin Pneumol pmid:3041401
Christman BW et al. Role of circulating platelets and granulocytes in PAF-induced pulmonary dysfunction in awake sheep. 1988 J. Appl. Physiol. pmid:3391901
Greenberg S et al. Extracellular nucleotides mediate Ca2+ fluxes in J774 macrophages by two distinct mechanisms. 1988 J. Biol. Chem. pmid:3392016
Etienne A et al. Possible involvement of platelet-activating factor in endotoxin-induced abortion. 1988 Prog. Clin. Biol. Res. pmid:3393560
Lazanas M et al. PAF of biological fluids in disease: IV. Levels in blood in allergic reactions induced by drugs. 1988 Arch. Dermatol. Res. pmid:3395143
Satoh K et al. Activity of platelet-activating factor (PAF) acetylhydrolase in plasma from patients with ischemic cerebrovascular disease. 1988 Prostaglandins pmid:3399678
Mazière JC et al. PAF-acether decreases low density lipoprotein degradation and alters lipid metabolism in cultured human fibroblasts. 1988 FEBS Lett. pmid:3402608
There is a case for PAF-acether antagonists. Abstracts of the conference. Paris, France, May 25-27, 1988. 1988 Prostaglandins pmid:3399682
Valone FH Platelet-activating factor binding and metabolism during human platelet aggregation. 1988 Thromb. Res. pmid:3400077
Roberts NM et al. Effect of a PAF antagonist, BN52063, on antigen-induced, acute, and late-onset cutaneous responses in atopic subjects. 1988 J. Allergy Clin. Immunol. pmid:3403863
Koenderman L et al. An improved method for the isolation of eosinophilic granulocytes from peripheral blood of normal individuals. 1988 J. Leukoc. Biol. pmid:3404069
Anderson GP and Fennessy MR Lipoxygenase metabolites as mediators of platelet activating factor-induced increased airways responsiveness to histamine in the guinea-pig. 1988 Agents Actions Suppl. pmid:3140616
Coyle AJ et al. The effect of the selective PAF antagonist BN 52021 on PAF- and antigen-induced bronchial hyper-reactivity and eosinophil accumulation. 1988 Eur. J. Pharmacol. pmid:3383997
Tokumura A et al. Study of platelet activating factor and its antagonists on rat colon strip with a new method avoiding tachyphylaxis. 1988 Eur. J. Pharmacol. pmid:3384001
Lewis MS et al. Hydrogen peroxide stimulates the synthesis of platelet-activating factor by endothelium and induces endothelial cell-dependent neutrophil adhesion. 1988 J. Clin. Invest. pmid:3198764
Makino S [Platelet activating factor in allergic reaction]. 1988 Arerugi pmid:3052368
Misawa M and Takata T Effects of platelet-activating factor on rat airways. 1988 Jpn. J. Pharmacol. pmid:3199608
Wasserman SI Platelet-activating factor as a mediator of bronchial asthma. 1988 Hosp. Pract. (Off. Ed.) pmid:3053741
Cunha FQ et al. Failure of PAF-acether to induce in vivo neutrophil migration. 1988 Agents Actions pmid:3055873
Kato T et al. Augmentation of DNA synthesis in guinea pig bone marrow cells by platelet-activating factor (PAF). 1988 Biochem. Biophys. Res. Commun. pmid:3202869
Foegh ML Eicosanoids and platelet activating factor mechanisms in organ rejection. 1988 Transplant. Proc. pmid:3059615
Roberts NM et al. Effect of a PAF antagonist, BN52063, on PAF-induced bronchoconstriction in normal subjects. 1988 Br J Clin Pharmacol pmid:3203062
Lagarde M Metabolism of fatty acids by platelets and the functions of various metabolites in mediating platelet function. 1988 Prog. Lipid Res. pmid:3060881
Freitas JC et al. Inhibition of platelet aggregation by manoalide: preliminary results. 1988 Braz. J. Med. Biol. Res. pmid:3203166
Pai JK et al. Phospholipase D catalyzes phospholipid metabolism in chemotactic peptide-stimulated HL-60 granulocytes. 1988 J. Biol. Chem. pmid:3165977
Collier M et al. Biochemical and pharmacological characterization of human embryo-derived platelet activating factor. 1988 Hum. Reprod. pmid:3204154
Rosario-Jansen T et al. Phospholipids chiral at phosphorus. Synthesis and stereospecificity of phosphorothioate analogues of platelet-activating factor. 1988 Biochemistry pmid:3167004
Prévost MC et al. Possible origins of PAF-acether and lyso-PAF-acether in rat lung alveoli secondary to hypoxia. 1988 Biochim. Biophys. Acta pmid:3167085
Nagpurkar A et al. Effect of rat phosphorylcholine-binding protein on platelet aggregation. 1988 Biochim. Biophys. Acta pmid:3167098
Armstead WM et al. Platelet activating factor: a potent constrictor of cerebral arterioles in newborn pigs. 1988 Circ. Res. pmid:3335052
Bonventre JV et al. PAF and PDGF increase cytosolic [Ca2+] and phospholipase activity in mesangial cells. 1988 Am. J. Physiol. pmid:3337246
Wallace JL and Whittle BJ Gastrointestinal damage induced by platelet-activating factor. Inhibition by the corticoid, dexamethasone. 1988 Dig. Dis. Sci. pmid:3338370
Benveniste J et al. Preformed PAF-acether and lyso PAF-acether are bound to blood lipoproteins. 1988 FEBS Lett. pmid:3338565
Michel L et al. Biosynthesis of paf-acether factor-acether by human skin fibroblasts in vitro. 1988 J. Immunol. pmid:3397536
Ponpipom MM et al. (+/-)-trans-2-(3-Methoxy-5-methylsulfonyl-4-propoxyphenyl)-5-(3,4,5- trimethoxyphenyl)tetrahydrofuran (L-659,989), a novel, potent PAF receptor antagonist. 1988 Biochem. Biophys. Res. Commun. pmid:2829894
Hwang SB Identification of a second putative receptor of platelet-activating factor from human polymorphonuclear leukocytes. 1988 J. Biol. Chem. pmid:2830276
Giovannini L et al. N-acetyl-beta-glucosaminidase (NAG) and alpha-glycosidase released by PAF in isolated perfused rat kidney. 1988 Int J Tissue React pmid:3294206
Marquis O et al. [3H]52770 RP, a platelet-activating factor receptor antagonist, and tritiated platelet-activating factor label a common specific binding site in human polymorphonuclear leukocytes. 1988 J. Pharmacol. Exp. Ther. pmid:2831350
Domingo MT et al. Presence of specific binding sites for platelet-activating factor (PAF) in brain. 1988 Biochem. Biophys. Res. Commun. pmid:2831903
Dillon PK et al. Vasoconstrictor effects of platelet-activating factor in the hamster cheek pouch microcirculation: dose-related relations and pathways of action. 1988 Circ. Res. pmid:2832096
Ma YH and Dunham EW Antagonism of the vasodilator effects of a platelet activating factor precursor in anesthetized spontaneously hypertensive rats. 1988 Eur. J. Pharmacol. pmid:2832188
Hellegouarch A et al. Lack of effect of atrial natriuretic factor on the tone induced in rat portal vein by platelet-activating factor. 1988 Eur. J. Pharmacol. pmid:2832190
Valone FH Identification of platelet-activating factor receptors in P388D1 murine macrophages. 1988 J. Immunol. pmid:2832476
Homma H and Hanahan DJ Attenuation of platelet activating factor (PAF)-induced stimulation of rabbit platelet GTPase by phorbol ester, dibutyryl cAMP, and desensitization: concomitant effects on PAF receptor binding characteristics. 1988 Arch. Biochem. Biophys. pmid:2833174
McGowan HM et al. Increased levels of platelet-activating factor (1-O-alkyl-2-acetylglycerophosphocholine) in blood after reversal of renal clip hypertension in the rat. 1988 Clin. Sci. pmid:3356112
Quinn MT et al. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis. 1988 Proc. Natl. Acad. Sci. U.S.A. pmid:3357891
Rees RS et al. Plasma components are required for platelet activation by the toxin of Loxosceles reclusa. 1988 Toxicon pmid:3245050
Tatsumi N et al. Neutrophil chemiluminescence induced by platelet activating factor and suppressed by C-reactive protein. 1988 Clin. Chim. Acta pmid:3359655
Hsueh W et al. Sequential release of leukotrienes and norepinephrine in rat bowel after platelet-activating factor. A mechanistic study of platelet-activating factor-induced bowel necrosis. 1988 Gastroenterology pmid:3360262
Hasegawa T and Nakajima S [Recent topics on platelet-activating-factor (PAF)]. 1988 Nippon Ika Daigaku Zasshi pmid:3360909
Chau LY and Jii YJ Characterization of 3H-labelled platelet activating factor receptor complex solubilized from rabbit platelet membranes. 1988 Biochim. Biophys. Acta pmid:2838093
Kimani G et al. Stimulation of eosinophil adherence to human vascular endothelial cells in vitro by platelet-activating factor. 1988 J. Immunol. pmid:3361129
Robertson DA et al. Negative inotropic effect of platelet-activating factor: association with a decrease in intracellular sodium activity. 1988 J. Pharmacol. Exp. Ther. pmid:3361438
Thelen M et al. Activation of monocytes by interferon-gamma has no effect on the level or affinity of the nicotinamide adenine dinucleotide-phosphate oxidase and on agonist-dependent superoxide formation. 1988 J. Clin. Invest. pmid:2838524
Terashita Z et al. Protective action of prostaglandin E1 (PGE1) against constrictor mediators in isolated rat heart and lung. 1988 Biochem. Pharmacol. pmid:2839198
Prpic V et al. Biochemical and functional responses stimulated by platelet-activating factor in murine peritoneal macrophages. 1988 J. Cell Biol. pmid:2839520
Kroegel C The potential pathophysiological role of platelet-activating factor in human diseases. 1988 Klin. Wochenschr. pmid:2839728
Eliakim R et al. Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone. 1988 Gastroenterology pmid:2901995
Page CP The role of platelet-activating factor in asthma. 1988 J. Allergy Clin. Immunol. pmid:3276759
Barnes PJ Platelet-activating factor and asthma. 1988 J. Allergy Clin. Immunol. pmid:3276760
Royall JA and Levin DL Adult respiratory distress syndrome in pediatric patients. I. Clinical aspects, pathophysiology, pathology, and mechanisms of lung injury. 1988 J. Pediatr. pmid:3276861
Vanhoutte PM Platelets, endothelium and blood vessel wall. 1988 Experientia pmid:3278917
Lellouch-Tubiana A et al. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Modulation by prostacyclin, platelet depletion, and selective antagonists. 1988 Am. Rev. Respir. Dis. pmid:3281530
Chung KF and Barnes PJ PAF antagonists. Their potential therapeutic role in asthma. 1988 Drugs pmid:3281823
Plante GE et al. Platelet activating factor antagonism with BN52021 protects the kidney against acute ischemic injury. 1988 Prostaglandins Leukot. Essent. Fatty Acids pmid:3231663
Stephens LR et al. Synthesis of myo-inositol 1,3,4,5,6-pentakisphosphate from inositol phosphates generated by receptor activation. 1988 Biochem. J. pmid:2845930
Santos JC et al. Effect of intrarenal infusion of synthetic PAF-acether in dogs. 1988 Rev. Esp. Fisiol. pmid:3231880
Ukena D and Sybrecht GW [Function of platelet activating factor in asthma]. 1988 Dtsch. Med. Wochenschr. pmid:2846251
Ostermann G et al. The degradation of platelet-activating factor in serum and its discriminative value in atherosclerotic patients. 1988 Thromb. Res. pmid:3232123
Croft KD et al. The effect of dietary fish oil and long-term salt loading on blood pressure and eicosanoid metabolism in spontaneously hypertensive rats. 1988 Clin. Exp. Pharmacol. Physiol. pmid:3271614
Ng DS and Wong K Effect of sulfhydryl reagents on PAF binding to human neutrophils and platelets. 1988 Eur. J. Pharmacol. pmid:2846326
Storch J et al. Influence of platelet activating factor and a nonmetabolizable analogue on superoxide production by bone marrow derived macrophages. 1988 J. Leukoc. Biol. pmid:2846728
Miller MJ et al. SOD prevents damage and attenuates eicosanoid release in a rabbit model of necrotizing enterocolitis. 1988 Am. J. Physiol. pmid:2847541
Fradin A et al. Inhibition of eicosanoid and PAF formation by dexamethasone in rat inflammatory polymorphonuclear neutrophils may implicate lipocortin 's'. 1988 Biochim. Biophys. Acta pmid:2848583
Lohmann HF et al. Idiopathic thrombocytopenia treated with Paf-acether antagonist WEB 2086. 1988 Lancet pmid:2903365
White HL and Faison LD Inhibition of lyso-PAF: acetyl-CoA acetyltransferase by salicylates and other compounds. 1988 Prostaglandins pmid:2903520